GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (WBO:1SXP) » Definitions » Enterprise Value

Schott Pharma AG KGaA (WBO:1SXP) Enterprise Value : €3,659.3 Mil (As of Dec. 15, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Schott Pharma AG KGaA Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Schott Pharma AG KGaA's Enterprise Value is €3,659.3 Mil. Schott Pharma AG KGaA's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €185.8 Mil. Therefore, Schott Pharma AG KGaA's EV-to-EBIT ratio for today is 19.70.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Schott Pharma AG KGaA's Enterprise Value is €3,659.3 Mil. Schott Pharma AG KGaA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was €251.8 Mil. Therefore, Schott Pharma AG KGaA's EV-to-EBITDA ratio for today is 14.53.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Schott Pharma AG KGaA's Enterprise Value is €3,659.3 Mil. Schott Pharma AG KGaA's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €948.6 Mil. Therefore, Schott Pharma AG KGaA's EV-to-Revenue ratio for today is 3.86.


Schott Pharma AG KGaA Enterprise Value Historical Data

The historical data trend for Schott Pharma AG KGaA's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Enterprise Value Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Enterprise Value
- - - -

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - 5,060.69 6,041.12 4,578.02

Competitive Comparison of Schott Pharma AG KGaA's Enterprise Value

For the Medical Instruments & Supplies subindustry, Schott Pharma AG KGaA's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Schott Pharma AG KGaA's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Schott Pharma AG KGaA's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Schott Pharma AG KGaA's Enterprise Value falls into.



Schott Pharma AG KGaA Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Schott Pharma AG KGaA's Enterprise Value for the fiscal year that ended in Sep. 2023 is calculated as

Schott Pharma AG KGaA's Enterprise Value for the quarter that ended in Jun. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA  (WBO:1SXP) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Schott Pharma AG KGaA's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3659.327/185.75
=19.70

Schott Pharma AG KGaA's current Enterprise Value is €3,659.3 Mil.
Schott Pharma AG KGaA's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €185.8 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Schott Pharma AG KGaA's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=3659.327/251.786
=14.53

Schott Pharma AG KGaA's current Enterprise Value is €3,659.3 Mil.
Schott Pharma AG KGaA's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €251.8 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Schott Pharma AG KGaA's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3659.327/948.556
=3.86

Schott Pharma AG KGaA's current Enterprise Value is €3,659.3 Mil.
Schott Pharma AG KGaA's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €948.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Schott Pharma AG KGaA Enterprise Value Related Terms

Thank you for viewing the detailed overview of Schott Pharma AG KGaA's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines